Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Do not assume compatibility with third-party, unverified, or non-Peptiology peptide batches
[1] These outcomes substantially exceeded placebo and represent some of the largest weight reductions reported in a controlled obesity trial
The most common side effects reported in retatrutide results from Phase 2 trials were gastrointestinal in nature, including nausea (affecting up to 45% of participants at higher doses), diarrhea, vomiting, and constipation
Research by Sikiric et al
The news highlights a difficult period for the Danish pharmaceutical giant as it struggles to regain market momentum against increasingly effective rival treatments
US$ 28.46
US$ 24.92
US$ 29.20
US$ 23.02
US$ 20.89
US$ 25.49
US$ 28.23
